Investigate the ability of ZnDDC to inhibit NFkB p65 and embryonic cancer stem cell markers (sox2, oct4 and nanog) in hypoxia cultured multiple myeloma cell lines using real-time PCR.

Healthcare&Medicine by Geoffrey

Multiple myeloma

Description

Investigate the ability of ZnDDC to inhibit NFkB p65 and embryonic cancer stem cell markers (sox2, oct4 and nanog) in hypoxia cultured multiple myeloma cell lines using real-time PCR.